REGISTERED NUMBER: 04792968 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026

FOR

MEDIFINANCE LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

R Cox

SECRETARY:

R Cox

REGISTERED OFFICE:

2 Manor Farm Court,

Old Wolverton Road,

Milton Keynes

Buckinghamshire

MK12 5NN

REGISTERED NUMBER:

04792968 (England and Wales)

ACCOUNTANTS:

Ad Valorem Accountancy Services Limited

Chartered Certified Accountants

2 Manor Farm Court

Old Wolverton Road

Old Wolverton

Milton Keynes

Buckinghamshire

MK12 5NN

FIXED ASSETS

Tangible assets

4

5,946

1,415

CURRENT ASSETS

Stocks

19,337

22,750

Debtors

5

68,993

58,885

Cash at bank and in hand

82,232

104,184

170,562

185,819

CREDITORS

Amounts falling due within one year

6

108,549

82,189

NET CURRENT ASSETS

62,013

103,630

TOTAL ASSETS LESS CURRENT LIABILITIES

67,959

105,045

CREDITORS

Amounts falling due after more than one year

7

-

(7,917

)

PROVISIONS FOR LIABILITIES

(1,130

)

-

NET ASSETS

66,829

97,128

CAPITAL AND RESERVES

Called up share capital

8

148

148

Capital redemption reserve

52

52

Retained earnings

66,629

96,928

SHAREHOLDERS' FUNDS

66,829

97,128

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 September 2026 and were signed by:

R Cox - Director

1.	STATUTORY INFORMATION

Medifinance Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

TANGIBLE FIXED ASSETS

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Improvements to property

-

10% on cost

Fixtures and fittings

-

20% on cost

Computer equipment

-

33% on cost

STOCKS

Work in progress is valued at the lower of cost and net realisable value.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

TAXATION

Taxation for the year comprises current tax and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2025 - 3 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

Improvements

and

Computer

to property

fittings

equipment

Totals

£

£

£

£

COST

At 1 April 2025

-

1,192

1,455

2,647

Additions

4,792

-

717

5,509

At 31 March 2026

4,792

1,192

2,172

8,156

DEPRECIATION

At 1 April 2025

-

457

775

1,232

Charge for year

240

238

500

978

At 31 March 2026

240

695

1,275

2,210

NET BOOK VALUE

At 31 March 2026

4,552

497

897

5,946

At 31 March 2025

-

735

680

1,415

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Trade debtors

59,550

45,387

Other debtors

9,443

13,498

68,993

58,885

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Bank loans and overdrafts

22,634

10,366

Trade creditors

74,296

54,036

Taxation and social security

6,504

16,235

Other creditors

5,115

1,552

108,549

82,189

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2026

2025

£

£

Bank loans

-

7,917

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2026

2025

value:

£

£

58

Ordinary A

1

58

58

40

Ordinary C & D

1

40

40

50

Ordinary E

1

50

50

148

148